Indefinite Delivery Contract 75N94024D00003
Award Date
9/30/24
Last Date to Order
9/29/29
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Pine Pharmaceuticals LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract, valued at $116,536.00, is for the provision of 503B compounding pharmaceutical products and services to support VA medical programs. The contract includes two task orders awarded to date. The first task order, valued at $48,136.00, was awarded...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland. The contract, valued at a ceiling of $2,500,000, is for the Pharmacokinetic Analysis Resource Center, which will provide support to clinical pharmacology and...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
The federal contract IDV is a single-award Blanket Purchase Agreement (BPA) issued by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Cambridge Isotope Laboratories, Inc. (Cambridge Isotope Labs), a foreign-owned, for-profit manufacturer of specialized materials including isotopically labeled compounds. The $10 million BPA, which runs through January 2026, allows NIH institutes to place orders for a variety of operation and maintenance items such as...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The purpose of this IDC is to obtain pharmacology studies, animal model development, and related services to support NCATS' Division of Preclinical Innovation drug...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Defense Medical Command (MEDCOM) to Metabolic Solutions, LLC, a for-profit limited liability company based in Nashua, New Hampshire. The single-award IDC has a ceiling value of $2,183,256.00 and a period of performance from July 16, 2024 to July 15, 2029. Under this IDC, Metabolic Solutions provides MEDCOM with analytical services, including stable isotope analysis of human biological samples such as urine, blood,...
This $49.9 million Indefinite Delivery Contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The contract is for research and development related to clinical studies under NIDA's Blueprint MedTech program, which focuses on medical technology development for nervous system disorders. Under this IDC, PPD will provide a range of services including developing...
The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022. Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's...
Cambridge Isotope Laboratories, Inc. (CIL) was awarded a single award blanket purchase agreement (BPA) by the National Institutes of Health (NIH) to provide gases, biological materials, chemicals, and media. The BPA has a potential value of $0 with a period of performance through January 2024 for ordering. Under the BPA, CIL has received multiple calls to supply stable isotope-labeled compounds to various NIH institutes, including the National Institute of Diabetes and Digestive and Kidney...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Sigma-Aldrich Corporation, a chemical supply company that primarily serves as a subcontractor for federal contracts. The $927,150 contract is for the acquisition of doubly labeled water isotopes to support the biomarker-based validation of diet and physical activity assessment tools for existing cohorts under the American Recovery and...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N94024D00003-75N94024F00001 | Pine Pharmaceuticals LLC | $15.0k | 9/30/24 | 9/29/29 | 9/11/24 | |
Delivery Order 75N94024D00003-75N94025F00001 | Pine Pharmaceuticals LLC | $158.9k | 4/14/25 | 4/13/26 | 4/14/25 | |
Delivery Order 75N94024D00003-75N94025F00002 | Pine Pharmaceuticals LLC | $81.7k | 7/22/25 | 4/30/26 | 7/22/25 |